"OS cell death trigger defined in rat brains," Harvard study

4 June 2006

Researchers at Harvard Medical School have defined a molecular signaling pathway by which oxidative stress triggers cell death, a finding that they believe could pave the way for new drug targets and diagnostic strategies for age-related diseases.

The results, which are reported in the June 2 issue of Cell, detail the molecular chain-of-events linking oxidative stress signals to cell death in neurons from rat brain. The Harvard team focused its attention on the function of a protein called MST, which had been previously implicated in cell death. It found that exposure of brain neurons to oxidative-stress signals stimulates the activity of MST and, once activated, MST instructs neurons to die. The researchers also found a tight link between MST and another family of molecules called FOXO proteins, which turn on genes in the nucleus

"A common molecular denominator in aging and many age-related diseases is oxidative stress," says the study's lead author, Azad Bonni. He added that the discovery of the MST-FOXO biochemical switch mechanism fills a gap in our understanding of how oxidative stress elicits biological responses in neurons, and may include besides cell death, neuronal dysfunction and neuronal recovery.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight